Water Polo Study Highlights Head Injury Risk
SATURDAY, May 25, 2019 -- Water polo players appear to face similar head injury risks as athletes in better-known sports, a new study FINDS.
"For years, water polos head trauma risks have been downplayed or
FDA Approves Piqray
FDA Approves Piqray (alpelisib) as First PI3K Inhibitor for Breast Cancer
May 24, 2019 -- Today, the U.S. Food and Drug Administration approved Piqray (alpelisib) tablets, to be used in combination with the FDA-approved endocrine t
Novartis Issues Voluntary Nationwide Recall of Promacta 12.5 mg for Oral Suspension Due to Potential Peanut Contamination
Audience: Consumer, Health Professional, Pharmacy
May 11, 2019 -- Novartis today announced a voluntary recall of three lots of Pr
Colon Cancer Increasingly Striking the Young Worldwide
FRIDAY, May 17, 2019 -- The rise in colon cases among younger adults thats been seen in the United States is also occurring in wealthier nations worldwide, new research shows.
In the decade leadin
FDA Approves Ruzurgi
FDA Approves Ruzurgi (amifampridine) for Children with Lambert-Eaton Myasthenic Syndrome
May 06, 2019 -- The U.S. Food and Drug Administration today approved Ruzurgi (amifampridine) tablets for the treatment of Lambert-Eaton myast
FDA Approves Broadened Indication for Xeomin (incobotulinumtoxinA) as First-Line Treatment for Blepharospasm (Involuntary Blinking) in Adult Patients
RALEIGH, N.C. – May 13, 2019 – Merz Americas announced today that the U.S. Food and Drug Administra